Cargando…

Rebuttal to: Melancholé: the Dark Side of Bile Acids and Its Cellular Consequences

Detalles Bibliográficos
Autores principales:	Bhushan, Bharat, Apte, Udayan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Point-Counterpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043300/ https://www.ncbi.nlm.nih.gov/pubmed/35202886 http://dx.doi.org/10.1016/j.jcmgh.2022.02.001

Ejemplares similares

Melancholé: The Dark Side of Bile Acids and Its Cellular Consequences
por: Zhou, Weinan, et al.
Publicado: (2022)

The Benevolent Bile: Bile Acids as Stimulants of Liver Regeneration
por: Bhushan, Bharat, et al.
Publicado: (2022)

Rebuttal to: The Benevolent Bile: Bile Acids as Stimulants of Liver Regeneration
por: Zhou, Weinan, et al.
Publicado: (2022)

Rebuttal to: Inflammation: The Straw That Broke the NAFLD Liver!
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Rebuttal From Drs Pandian, Murgu, and Lamb
por: Pandian, Vinciya, et al.
Publicado: (2021)

Rebuttal to: Liver Steatosis is a Driving Factor of Inflammation
por: Raeman, Reben
Publicado: (2022)

Rebuttal From Drs Brenner, Feller-Kopman, and De Cardenas
por: Brenner, Michael J., et al.
Publicado: (2021)

Rebuttal to: In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Sugimoto, Shinya, et al.
Publicado: (2021)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Guiu, Jordi, et al.
Publicado: (2021)

Rebuttal From Drs Hick and Hanfling
por: Hick, John L., et al.
Publicado: (2022)

Rebuttal From Drs Sulmasy and Maldonado
por: Sulmasy, Daniel P., et al.
Publicado: (2021)

Rebuttal From Dr Tritschler et al
por: Tritschler, Tobias, et al.
Publicado: (2022)

Rebuttal From Dr White et al
por: White, Douglas B., et al.
Publicado: (2022)

Rebuttal From Dr David Jimenez et al
por: Jimenez, David, et al.
Publicado: (2022)

Rebuttal to: Confusion on Cell Fusion
por: Sutton, Thomas L., et al.
Publicado: (2020)

Rebuttal to: Digesting the Importance of Cell Fusion in the Intestine
por: Ramadan, Rana, et al.
Publicado: (2020)

Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations
por: Home, Philip D.
Publicado: (2013)

Should Local Excision After Neoadjuvant Therapy Be Included in the National Guidelines for the Treatment of Locally Advanced Rectal Cancer?
por: Aref, Amr, et al.
Publicado: (2022)

Inflammation: The Straw That Broke the NAFLD Liver!
por: Raeman, Reben
Publicado: (2022)

Liver Steatosis is a Driving Factor of Inflammation
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

The Australian Curriculum over a decade: the status of the promises, problems, and possibilities
por: Price, Deborah
Publicado: (2022)

Pathophysiological Roles of Ductular Reaction in Liver Inflammation and Hepatic Fibrogenesis
por: Sato, Keisaku, et al.
Publicado: (2022)

Ductular Reaction and Liver Regeneration: Fulfilling the Prophecy of Prometheus!
por: Monga, Satdarshan P., et al.
Publicado: (2022)

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
por: Khan, Mahfuzul H., et al.
Publicado: (2009)

Point: Steady Progress and Current Challenges in Clinical Islet Transplantation
por: Mineo, Davide, et al.
Publicado: (2009)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
por: Kalantar-Zadeh, Kamyar
Publicado: (2012)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: Time to dispense with the hemoglobin A1C in end-stage kidney disease
por: Freedman, Barry I.
Publicado: (2012)

Response to commentary “Zinc is decreased in prostate cancer: an established relationship of prostate cancer!”
por: Banas, Agnieszka Maria, et al.
Publicado: (2010)

Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target
por: Ceriello, Antonio
Publicado: (2010)

Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
por: Riddle, Matthew C.
Publicado: (2010)

Mitochondrial Deficiency Is Associated With Insulin Resistance
por: Goodpaster, Bret H.
Publicado: (2013)

“Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance
por: Holloszy, John O.
Publicado: (2013)

Glucose Variability: Where It Is Important and How to Measure It
por: DeVries, J. Hans
Publicado: (2013)

Glucose Variability
por: Service, F. John
Publicado: (2013)

Insulin Analogs—Is There a Compelling Case to Use Them? No!
por: Davidson, Mayer B.
Publicado: (2014)

2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management
por: Terkelsen, Christian Juhl, et al.
Publicado: (2013)

Validity of Meta-analysis in Diabetes: Meta-analysis Is an Indispensable Tool in Evidence Synthesis
por: Golden, Sherita Hill, et al.
Publicado: (2013)

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence
por: Malanda, Uriëll L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mlhlkpfl2encc981kf3qj2hsjo